Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery

Drug Delivery and Translational Research
Timothy E AndrewsDaniel A Harki

Abstract

The recognition that the persistence of cancer stem cells (CSCs) in patients following chemotherapy can result in disease relapse underscores the necessity to develop therapeutics against those cells. CSCs display a unique repertoire of cell surface macromolecules, which have proven essential for their characterization and isolation. Additionally, CSC-specific cell surface macromolecules or markers provide targets for the development of specific agents to destroy them. In this review, we compiled those cell surface molecules that have been validated as CSC markers for many common blood and solid tumors. We describe the unique chemical and structural features of the most common cell surface markers, as well as recent efforts to deliver chemotherapeutic agents into CSCs by targeting those macromolecules.

References

Jan 1, 1976·The Journal of Antibiotics·H UmezawaT Takeuchi
Feb 1, 1992·The Journal of Cell Biology·S Jalkanen, M Jalkanen
Jan 1, 1991·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G Mathé
Mar 1, 1988·The Journal of Clinical Investigation·R J BerensonI D Bernstein
Aug 20, 1987·The New England Journal of Medicine·P J FialkowR Veith
Apr 1, 1994·International Immunology·N Toyama-Sorimachi, M Miyasaka
Oct 15, 1993·Science·S BaumheterL A Lasky
Apr 1, 1994·The Journal of Cell Biology·S V LitvinovS O Warnaar
Jul 1, 1993·The Journal of Cell Biology·R J PeachA Aruffo
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·L HealyT Enver
Jan 1, 1996·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·K EzawaK Dobashi
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·A WeigmannW B Huttner
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·A Y LiuG van den Engh
May 26, 1999·Experimental Hematology·D S DonnellyD S Krause
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·X JiangC Eaves
Nov 11, 1999·European Journal of Immunology·T UlyanovaM L Thomas
Dec 22, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·M BalzarS V Litvinov
Mar 11, 2000·The Journal of Clinical Investigation·M H SiegelmanP Estess
Feb 15, 2001·Nature Structural Biology·M M ThunnissenJ Z Haeggström
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Apr 18, 2001·Trends in Cell Biology·E J Brown, W A Frazier
Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·C VitaleM C Mingari
Nov 2, 2001·Nature·T ReyaI L Weissman
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Stefanie NaundorfTorsten Dreier
Aug 23, 2002·Leukemia Research·Anjali S Advani, Ann Marie Pendergast
Aug 28, 2002·Reviews in Clinical and Experimental Hematology·Stefan FaderlHagop M Kantarjian
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Apr 12, 2003·Experimental Cell Research·Manon J WinterSergey V Litvinov
Aug 7, 2003·Current Opinion in Pharmacology·Nitin K Damle, Philip Frost

❮ Previous
Next ❯

Citations

May 4, 2016·Current Stem Cell Reports·Efraín A Cermeño, Andrés J García
Aug 10, 2015·Biochimica Et Biophysica Acta·Emyr BakkerMarija Krstic-Demonacos
Jan 30, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Alireza MirzaeiZahra Madjd
Jul 23, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Suresh Kumar SwaminathanJayanth Panyam
Aug 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Peyman RanjiAli Mohammad Alizadeh
Sep 14, 2018·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Sara SoltanianBehjat Kalantari Khandani
Dec 3, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Sahar F Mansour, Maha M Atwa
Oct 24, 2020·Drug Delivery and Translational Research·Jin CaoJayanth Panyam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.